Literature DB >> 6265207

Endotoxaemia in the horse.

G E Burrows.   

Abstract

Endotoxins are non-protein fragments of the cell wall of Gram-negative bacteria. They must be absorbed into the circulation to produce disease and systemic effects are similar, regardless of bacterial source. Absorption of endotoxins occurs in obstructive bowel disease and may play a significant part in determining the severity of the disease. Many of the responses to experimentally administered endotoxin are identical to those of bowel diseases or the horse and include circulatory, haematological and metabolic alterations. Therapeutic approaches are indirect and include many drugs currently employed in equine practice. The agents are directed toward mediators of the disease rather than the endotoxins themselves and include fluids, corticosteroids, anti-inflammatory drugs, energy sources and vasoactive drugs. The rationale for use and dosages are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265207     DOI: 10.1111/j.2042-3306.1981.tb04120.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  4 in total

1.  Klebsiella oxytoca Septicemia due to Intravenous Administration of a Contaminated Amino-acid Solution to Three Horses.

Authors:  M J Hazlett; D C Goodrow; J A Lynch; M K Kierstead
Journal:  Can Vet J       Date:  1987-07       Impact factor: 1.008

2.  Characterization of equine E-selectin.

Authors:  J F Hedges; C D Demaula; B D Moore; B E McLaughlin; S I Simon; N J MacLachlan
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

3.  Some endotoxin-induced clinical and biochemical changes in plasma of camels (Camelus dromedarius).

Authors:  A M Al-Dughaym
Journal:  Vet Res Commun       Date:  2004-11       Impact factor: 2.459

4.  Quality Control of Compounded Crystalloid Fluids for Intravenous Delivery to Horses.

Authors:  C B Magnusson; K P Poulsen; J A Budde; F A Hartmann; N A Aulik; S M Raabis; A S D Moreira; B J Darien; S F Peek
Journal:  J Vet Intern Med       Date:  2017-11-08       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.